Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567515-13-000001
Filing Date
2013-01-22
Accepted
2013-01-22 17:14:46
Documents
2
Period of Report
2013-01-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 5690
2 POWER OF ATTORNEY powerofattorneyipmdgmbh.txt EX-24 2993
  Complete submission text file 0001567515-13-000001.txt   10248
Mailing Address 4452 BELTWAY DRIVE ADDISON TX 75001
Business Address 4452 BELTWAY DRIVE ADDISON TX 75001 214-905-5145
ULURU INC. (Issuer) CIK: 0001168220 (see all company filings)

EIN.: 412118656 | State of Incorp.: NV | Fiscal Year End: 0913
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ULURU INC. 4452 BELTWAY DRIVE ADDISON TX 75001
Business Address SCHREYVOGELGASSE 3/5 VIENNA C4 1010AT 214-505-5145
IPMD GmbH (Reporting) CIK: 0001567515 (see all company filings)

Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-33618 | Film No.: 13540986